Literature DB >> 23958419

Diagnostic accuracy of three-dimensional contrast-enhanced MR angiography at 3-T for acute pulmonary embolism detection: comparison with multidetector CT angiography.

Long Jiang Zhang1, Song Luo, Benjamin M Yeh, Chang Sheng Zhou, Chun Xiang Tang, Yan'e Zhao, Lin Li, Ling Zheng, Wei Huang, Guang Ming Lu.   

Abstract

BACKGROUND: Three-dimensional contrast-enhanced MR pulmonary angiography (MRPA) is a suitable option for pulmonary embolism (PE) detection. However, there have been few reports on the diagnostic accuracy of MRPA for PE detection in a 3-T MR system. The purpose of this study was to evaluate the accuracy of MRPA in a 3-T MR system to detect acute PE with multidetector CT pulmonary angiography (CTPA) as reference standard.
METHODS: Twenty-seven patients (18 males and 9 females, mean age 38.9±14.4 years) underwent both MRPA and CTPA within 3 days (range, 0-3 days) for evaluating PE. Pulmonary emboli in MRPA were independently analyzed on a per-patient and per-lobe basis by two radiologists. CTPA was regarded as reference standard, which was evaluated by another two radiologists in consensus. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy for PE detection were calculated. Weighted κ values were calculated to evaluate agreement between readers.
RESULTS: Twenty-four patients had PE in 55 lung lobes in CTPA, while 3 patients had no PE detected. Readers 1 and 2 correctly detected 47 and 46 lung lobes having clots in 24 and 23 patients, corresponding to sensitivities, specificities, PPV, NPV, and accuracies of 100%, 100%, 100%, 100%, 100%; 100%, 66.7%, 96.0%, 100%, 96.4% on a per-patient basis and 85.5%, 100%, 100%, 90.9%, 94.1%; 83.6%, 93.7%, 90.2%, 89.2%, 89.6% on a per-lobe basis; respectively. Excellent inter-reader agreement (κ values=1.00 and 0.934; both P<0.001) were found for detecting PE on a per-patient and per-lobe analysis.
CONCLUSION: Three-dimensional contrast-enhanced MRPA with a 3-T MR system is a suitable alternative modality to CTPA to detect PE on a per-patient basis based on this small cohort study.
© 2013.

Entities:  

Keywords:  Magnetic resonance imaging; Pulmonary embolism; Tomography, X-ray computed

Mesh:

Year:  2013        PMID: 23958419     DOI: 10.1016/j.ijcard.2013.07.228

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Diagnostic performance of contrast-enhanced and unenhanced combined pulmonary artery MRI and magnetic resonance venography techniques in the diagnosis of venous thromboembolism.

Authors:  Furkan Kaya; Furkan Ufuk; Nevzat Karabulut
Journal:  Br J Radiol       Date:  2019-01-10       Impact factor: 3.039

2.  Magnetic Resonance Imaging of Pulmonary Embolism: Diagnostic Accuracy of Unenhanced MR and Influence in Mortality Rates.

Authors:  Lilian Pasin; Matheus Zanon; Jose Moreira; Ana Luiza Moreira; Guilherme Watte; Edson Marchiori; Bruno Hochhegger
Journal:  Lung       Date:  2017-01-23       Impact factor: 2.584

3.  Diagnostic accuracy of true fast imaging with steady-state precession, MR pulmonary angiography and volume-interpolated body examination for pulmonary embolism compared with CT pulmonary angiography.

Authors:  Qing Fu; Qiguang Cheng; Xiangchuang Kong; Hui Ma; Ziqiao Lei
Journal:  Exp Ther Med       Date:  2020-11-17       Impact factor: 2.447

4.  Diagnosis efficiency for pulmonary embolism using magnetic resonance imaging method: a meta-analysis.

Authors:  Kuitao Yue
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Clinical outcomes after magnetic resonance angiography (MRA) versus computed tomographic angiography (CTA) for pulmonary embolism evaluation.

Authors:  Michael D Repplinger; Scott K Nagle; John B Harringa; Aimee T Broman; Christopher R Lindholm; Christopher J François; Thomas M Grist; Scott B Reeder; Mark L Schiebler
Journal:  Emerg Radiol       Date:  2018-05-10

6.  Impact of extracardiac findings during cardiac MR on patient management and outcome.

Authors:  Vincent Dunet; Heloise Barras; Xavier Boulanger; Pierre Monney; Salah D Qanadli; Reto Meuli; Juerg Schwitter; Catherine Beigelman-Aubry
Journal:  Med Sci Monit       Date:  2015-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.